Abstract
Genetic immunization has been useful in vaccine technology and can also be used to generate immune responses to novel proteins. It is particularly useful when a properly folded protein is difficult to isolate or make in recombinant form and the required antibody must recognize a conformational epitope. Injecting cDNA allows the protein to be expressed in native form by the animal's own cells in vivo and then presented to the immune system. Genetic immunization is most effective for the generation of antibodies if the cDNA encodes for secreted or cell-surface proteins to make them accessible to the immune system. It also has been successful in generating antibody responses to difficult protein targets such as G-coupled protein receptors, ion channel proteins, and other multiple membrane-spanning proteins. High-affinity antibodies tend to be favored because the proteins are expressed at low levels and are constantly present for presentation to the immune system. In addition, several months can be saved obtaining sufficient amounts of properly folded, soluble recombinant protein or high-expressing transfected cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.